Form 4: Elanco EVP Acquires Deferred Stock Units

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, acquired 60.7916 deferred stock units at a price of $23.27 per unit.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., acquired 60.7916 Deferred Stock Units (DSUs).
• The transaction occurred on November 28, 2025.
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The DSUs were acquired at a price of $23.27 per unit.
• Following this transaction, Modi beneficially owns 7,291.0368 DSUs directly.
• These DSUs will settle in cash or shares of common stock upon termination of employment or in a specified future year, as per the Executive Deferral and Stock Match Plan.

Sentiment

Score: 7

Explanation: The acquisition of deferred stock units by a key executive, even if part of a compensation plan, generally reflects a positive alignment of interests and potential confidence in the company's long-term prospects. It's a routine, slightly positive event.

Positives

• An executive acquiring additional equity (even deferred units) can signal confidence in the company's future performance.
• The acquisition is part of an Executive Deferral and Stock Match Plan, indicating a structured compensation and retention strategy.

Risks

• The value of the deferred stock units is tied to the future performance of Elanco's common stock, exposing the holder to market risk.
• Settlement of the DSUs is contingent on future events (termination of employment or a specified future year), introducing a time-based risk.

Future Outlook

The filing indicates that the deferred stock units will settle in cash or shares of common stock following termination of employment or during a specified future year, aligning with the company's Executive Deferral and Stock Match Plan. This suggests a long-term incentive structure for the executive.

Industry Context

This filing is a routine insider transaction report. In the animal health industry, executive compensation often includes equity-based incentives like DSUs to align management interests with shareholder value over the long term.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) as part of executive compensation is a common practice across various industries, including animal health, for long-term incentive alignment and retention.
• Companies like Zoetis Inc. (ZTS) and IDEXX Laboratories, Inc. (IDXX), also prominent in the animal health sector, similarly utilize equity-based awards for their executives.
• The specific number of units and price are particular to Elanco's compensation structure and stock valuation at the time of the grant.

Corporate Governance

Related Party Transactions

• The transaction involves an executive and the company, which is a standard compensation event reported on Form 4.

Stakeholder Impact

• Shareholders: The acquisition of DSUs by an executive aligns their interests with shareholders, potentially fostering long-term value creation.
• Employees: This reflects the company's executive compensation strategy, which may influence broader employee incentive programs.

Next Steps

• The deferred stock units will settle in cash or shares of Company common stock following termination of employment or during a specified future year.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units by an executive as part of a compensation plan. While it signals executive alignment, it does not provide new fundamental information to warrant a change in investment recommendation. It's a neutral event for immediate stock price action.

Keywords

Elanco Animal Health, ELAN, Rajeev A. Modi, Deferred Stock Units, DSU, Insider Trading, Executive Compensation, Stock Acquisition, SEC Form 4, Animal Health